What is Stockpools?

Need an account?

Play for free for a chance to win.

Join the Stockpools community today

Register now

Stockpools on your Phone

Follow Stockpools

Abattis, GD Pharma sign distribution deal for S. Korea


VANCOUVER, British Columbia, Oct. 03, 2017 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to announce it has reached a definitive agreement with Global Damon Pharma (“GD Pharma”) of South Korea, to distribute and sell Abattis’ product lines exclusively in South Korea. The agreement allows GD Pharma to begin sales of Abattis products in South Korea effective immediately.

Click here to read the original article.